Literature DB >> 2243398

CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses.

P Lusso1, F Lori, R C Gallo.   

Abstract

Although human immunodeficiency virus (HIV) is the causative agent of the acquired immunodeficiency syndrome and related disorders, it has been suggested that viral cofactors may accelerate the progression of the disease. We present evidence that human T lymphoid cells productively coinfected by HIV type 1 (HIV-1) and human T-cell leukemia virus type I (HTLV-I) or HTLV-II generate a progeny of phenotypically mixed viral particles that allow the penetration of HIV-1 into previously nonsusceptible CD4- human cells, including mature CD8+ T lymphocytes, B lymphoid cells, epithelial cells, and skeletal muscle cells. The infection is independent of the major HIV-1 receptor, (i.e., the CD4 glycoprotein) since OKT4a, a neutralizing anti-CD4 monoclonal antibody, fails to block the penetration of HIV-1. Similarly, infection is not inhibited by monoclonal antibody M77, directed toward the neutralizing loop of the gp120 envelope glycoprotein of HIV-1. In contrast, pretreatment of the virus stock with HTLV-I-neutralizing human serum completely abolishes the penetration of phenotypically mixed HIV-1 into CD4- cells. These results suggest that HTLV-I or HTLV-II may increase the pathogenicity of HIV-1 by broadening the spectrum of its cellular tropism and, thus, favoring its spread within the organism of coinfected hosts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2243398      PMCID: PMC248817     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.

Authors:  H Lee; P Swanson; V S Shorty; J A Zack; J D Rosenblatt; I S Chen
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

Review 2.  AIDS in 1988.

Authors:  R C Gallo; L Montagnier
Journal:  Sci Am       Date:  1988-10       Impact factor: 2.142

3.  Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

Authors:  P Lusso; B Ensoli; P D Markham; D V Ablashi; S Z Salahuddin; E Tschachler; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

4.  Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad.

Authors:  C Bartholomew; W Blattner; F Cleghorn
Journal:  Lancet       Date:  1987-12-19       Impact factor: 79.321

5.  Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein.

Authors:  E Seto; T S Yen; B M Peterlin; J H Ou
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  HIV-1, HIV-2, and HTLV-I infection in high-risk groups in Brazil.

Authors:  E Cortes; R Detels; D Aboulafia; X L Li; T Moudgil; M Alam; C Bonecker; A Gonzaga; L Oyafuso; M Tondo
Journal:  N Engl J Med       Date:  1989-04-13       Impact factor: 91.245

7.  Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

Authors:  J R Rusche; K Javaherian; C McDanal; J Petro; D L Lynn; R Grimaila; A Langlois; R C Gallo; L O Arthur; P J Fischinger
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  Human T cell leukemia viruses use a receptor determined by human chromosome 17.

Authors:  M A Sommerfelt; B P Williams; P R Clapham; E Solomon; P N Goodfellow; R A Weiss
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

9.  Double infections of single cells with ECHO 7 and Coxsackie A9 viruses.

Authors:  H ITOH; J L MELNICK
Journal:  J Exp Med       Date:  1959-04-01       Impact factor: 14.307

10.  In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

Authors:  P Lusso; P D Markham; E Tschachler; F di Marzo Veronese; S Z Salahuddin; D V Ablashi; S Pahwa; K Krohn; R C Gallo
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

2.  HTLV-II does not adversely affect the natural history of HIV-1 infection in intravenous drug users.

Authors:  G Magnani; G Elia; C Casoli; C Calzetti; A Degli Antoni; F Fiaccadori
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

3.  Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.

Authors:  A M Borman; C Quillent; P Charneau; C Dauguet; F Clavel
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

4.  Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis.

Authors:  L Flamand; R W Crowley; P Lusso; S Colombini-Hatch; D M Margolis; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

5.  Human cytomegalovirus inhibits human immunodeficiency virus replication in cells productively infected by both viruses.

Authors:  V Koval; C Clark; M Vaishnav; S A Spector; D H Spector
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  Human T-lymphotropic virus type 2 (HTLV-2) provirus in circulating cells of the monocyte/macrophage lineage in patients dually infected with human immunodeficiency virus type 1 and HTLV-2 and having predominantly sensory polyneuropathy.

Authors:  G Zehender; L Meroni; S Varchetta; C De Maddalena; B Cavalli; M Gianotto; A B Bosisio; C Colasante; G Rizzardini; M Moroni; M Galli
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

7.  Human T-cell leukemia virus type II infection among high risk groups and its influence on HIV-1 disease progression.

Authors:  M Giacomo; E G Franco; C Claudio; C Carlo; D A Anna; D Anna; F Franco
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

8.  Multiple isolates and characteristics of human T-cell leukemia virus type II.

Authors:  W W Hall; H Takahashi; C Liu; M H Kaplan; O Scheewind; S Ijichi; K Nagashima; R C Gallo
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Effect of reciprocal complementation of two defective human immunodeficiency virus type 1 (HIV-1) molecular clones on HIV-1 cell tropism and virulence.

Authors:  F Lori; L Hall; P Lusso; M Popovic; P Markham; G Franchini; M S Reitz
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

Review 10.  Semen alloantigens and lymphocytotoxic antibodies in AIDS and ICL.

Authors:  R S Root-Bernstein; S H DeWitt
Journal:  Genetica       Date:  1995       Impact factor: 1.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.